The authors found that malignant and benign T cells from leukemic CTCL patients expressed lower levels of IFNγ and higher levels of IL-4 and IL-13 than T cells from healthy controls. The gene discussed is IL13; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.